Y-Intercept (HK)’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.48M Sell
55,681
-102,593
-65% -$4.87M 0.05% 584
2026
Q1
$8.16M Buy
158,274
+87,639
+124% +$6.14M 0.15% 155
2025
Q4
$6.51M Sell
70,635
-28,414
-29% -$2.72M 0.15% 147
2025
Q3
$7.35M Buy
99,049
+83,883
+553% +$8.49M 0.18% 118
2025
Q2
$1.97M Buy
+15,166
New +$2.2M 0.05% 610
2025
Q1
Sell
-2,488
Closed -$461K 1396
2024
Q4
$461K Buy
+2,488
New +$483K 0.03% 763
2024
Q3
Sell
-34,695
Closed -$4.64M 1545
2024
Q2
$4.64M Buy
+34,695
New +$6.57M 0.25% 75
2023
Q4
Sell
-11,044
Closed -$2.19M 1425
2023
Q3
$2.19M Buy
11,044
+9,844
+820% +$2.48M 0.21% 121
2023
Q2
$390K Buy
1,200
+43
+4% +$12.3K 0.04% 672
2023
Q1
$271K Sell
1,157
-3,174
-73% -$802K 0.03% 822
2022
Q4
$1.09M Buy
+4,331
New +$923K 0.16% 178
2022
Q2
Sell
-975
Closed -$250K 1017
2022
Q1
$250K Buy
+975
New +$223K 0.06% 529

Other funds holding INSP

Y-Intercept (HK)'s INSP Position: Q2 2026 in Review

Y-Intercept (HK) reduced its Inspire Medical Systems (INSP) stake by 65% in Q2 2026, selling an estimated $4.87M and leaving 55,681 shares worth $2.48M. The position accounts for 0.05% of the portfolio, ranked #584.

Y-Intercept (HK) first reported a position in INSP in Q1 2022 and has held it in 12 quarters since. The position peaked at $8.16M in Q1 2026. 43 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Y-Intercept (HK) held 55,681 shares of Inspire Medical Systems worth $2.48M as of Q2 2026.
  • Y-Intercept (HK) sold 102,593 Inspire Medical Systems shares in Q2 2026, an estimated $4.87M.
  • Inspire Medical Systems made up 0.05% of Y-Intercept (HK)'s portfolio in Q2 2026, its #584 holding.
  • Y-Intercept (HK) first reported a position in Inspire Medical Systems in Q1 2022 and has held it in 12 quarters since.
  • Y-Intercept (HK)'s Inspire Medical Systems position peaked at $8.16M in Q1 2026.
  • 43 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.